AMRS - Amyris, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Amyris, Inc.

5885 Hollis Street
Suite 100
Emeryville, CA 94608
United States

SectorBasic Materials
IndustrySpecialty Chemicals
Full Time Employees414

Key Executives

NameTitlePayExercisedYear Born
Mr. John G. MeloPres, CEO & Director1.8MN/A1966
Ms. Kathleen ValiasekChief Financial Officer615.47kN/A1964
Mr. Eduardo AlvarezChief Operating Officer534.26kN/A1964
Ms. Nicole KelseyGen. Counsel & Sec.704.16kN/A1967
Dr. Joel R. CherryPres of R&DN/AN/A1961
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Amyris, Inc., an integrated renewable products company, engages in the research, development, and production of ingredients for the health and wellness, clean beauty, and flavors and fragrances markets worldwide. It applies its bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products. The company delivers its products and services under the No Compromise name across various markets, including specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals. It has a collaboration agreement with Yifan Pharmaceutical Co., Ltd. and Givaudan SA. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.

Corporate Governance

Amyris, Inc.’s ISS Governance QualityScore as of January 1, 2019 is 10. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.